BC Week In Review | Jun 16, 2014
Company News

Abzena, Alpha Cancer deal

Abzena's PolyTherics Ltd. subsidiary partnered with Alpha Cancer to develop drug conjugates to treat cancer. PolyTherics will use its ThioBridge linker technology to attach an undisclosed cytotoxic drug to Alpha Cancer's recombinant human alpha fetoprotein...
BC Week In Review | Feb 24, 2014
Company News

Alpha Cancer, Bradmer deal

The companies signed a letter of intent to combine businesses through a reverse merger with the newco to be named Alpha Cancer Technologies Inc. The close is subject to Alpha Cancer completing a private placement...
Items per page:
1 - 2 of 2